ResMed Inc. Derivative Asset
ResMed Inc. (RMD) had Derivative Asset of $5.22 million as of 2026-06-30, per its 10-K filed 2026-08-13.
Financial Statements › Balance Sheet › Assets
us-gaap:DerivativeAssets · last filed 2026-08-13
- 2026-06-30: Derivative Asset $5.22M.
- 2026-03-31: Derivative Asset $7.39M.
- 2025-12-31: Derivative Asset $7.52M.
- 2025-09-30: Derivative Asset $8.07M.
| Period end | Derivative Asset |
|---|---|
| 2026-06-30 | $5.22M 10-K · filed 2026-08-13 |
| 2026-03-31 | $7.39M 10-Q · filed 2026-05-01 |
| 2025-12-31 | $7.52M 10-Q · filed 2026-01-30 |
| 2025-09-30 | $8.07M 10-Q · filed 2025-10-31 |
| 2025-06-30 | $6.81M 10-K · filed 2026-08-13 |
| 2025-03-31 | $9.90M 10-Q · filed 2025-04-24 |
| 2024-12-31 | $12.56M 10-Q · filed 2025-01-31 |
| 2024-09-30 | $24.66M 10-Q · filed 2024-10-25 |
| 2024-06-30 | $2.43M 10-K · filed 2025-08-08 |
| 2024-03-31 | $1.81M 10-Q · filed 2024-04-26 |
| 2023-12-31 | $21.37M 10-Q · filed 2024-01-25 |
| 2023-09-30 | $4.33M 10-Q · filed 2023-10-27 |
| 2023-06-30 | $2.40M 10-K · filed 2024-08-09 |
| 2023-03-31 | $5.45M 10-Q · filed 2023-04-28 |
| 2022-12-31 | $14.62M 10-Q · filed 2023-01-27 |
| 2022-06-30 | $160.00K 10-K · filed 2023-08-11 |